FDA Clearance Tracker · P910056-S010
EN VISTA ONE PEICE HYDROPHOBIC ACRYLIC LENS, MODEL MX60
Last checked: Nov 20, 2026Latest source record: May 30, 2012 (this decision)Source: openFDAMethods & limitations
Decided
May 30, 2012
Approved
Time to decision
261 days
Received Sep 12, 2011. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P910056-S010
- Device name
- EN VISTA ONE PEICE HYDROPHOBIC ACRYLIC LENS, MODEL MX60
- Applicant
- Bausch & Lomb, Inc.
- Applicant location
- Irvine, CA
- Received
- Sep 12, 2011
- Decided
- May 30, 2012
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P910056
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR A MATERIAL CHANGE AND DESIGN MODIFICATIONS (3-PIECE TO 1-PIECE DESIGN AND ASPHERIC SURFACE) TO THE APPROVED BAUSCH & LOMB SILICONE LENS C31UB. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME ENVISTA ONE-PIECE HYDROPHOBIC ACRYLIC INTRAOCULAR LENS, MODEL MX60 AND IS INDICATED FOR PRIMARY IMPLANTATION FOR THE VISUAL CORRECTION OF APHAKIA IN ADULT PATIENTS IN WHOM THE CATARACTOUS CRYSTALLINE LENS HAS BEEN REMOVED.
Source documents
Other decisions for Bausch & Lomb, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact Lens510(k)
K262941 · Decided Oct 16, 2026 · 56 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
P240005 · Decided Oct 10, 2024 · 216 days after receipt
Device type: Lens, multifocal intraocular (MFK) · Ophthalmology
K192005 · Decided Oct 4, 2019 · 67 days after receipt
Device type: Folders And Injectors, Intraocular Lens (Iol) (MSS) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.